Home >
News >
ACUTE LEUKAEMIAS: SAVE THE DATE #ESHAL2022
ACUTE LEUKAEMIAS: SAVE THE DATE #ESHAL2022
October 25, 2021
ESH 3rd How to Diagnose and Treat
ACUTE LEUKAEMIAS
March 11-13, 2022
Budapest, Hungary
#ESHAL2022
It is already available:
STAY TUNED: REGISTRATION OPENING SOON
Looking forward to meeting you face to face in Budapest!
About the Conference:
ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management which is greatly facilitated by and discussion of real clinical cases. An important incentive will be to promote interaction between the speakers and participants.
Novel and still evolving insights into the biology and diagnosis of acute leukaemias, including acute myeloid leukaemias (AMLs) and acute lymphoblastic leukaemias (ALL), has resulted in new drug approvals and new therapeutic options to treat newly-diagnosed as well as relapsed/refractory disease.
The programme of this “
3rd How to Diagnose and Treat: Acute Leukaemias” meeting will integrate of genomic analysis and cutting-edge technics in routine diagnosis, gene mutation-directed therapies and new standard treatment algorithms, allogeneic haematopoietic stem cell (HSCT) transplantation and innovative immunotherapies, as well as diagnosis and management of rare acute leukaemia subtypes.
CONFERENCE MAIN TOPICS:
• Diagnosis and rare diseases
• Measurable Residual Disease (MRD)
• Leukaemia treatment dilemmas
• Intensive chemotherapy for older fit patients
• MRD level before transplant
• Leukaemia treatment challenges
• Ph-positive ALL
• CAR-T cell for ALL patients
• Immune therapies to treat leukaemia patients
• Haematopoietic stem cell transplantation
For more information, click here!
With the support of*:
Major Conference Partner
*******
Level 1 Conference Partner
*******
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.